Plasswilm, Ludwig

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013


Hendrickx, Alexandra; Cozzio, Antonio; Plasswilm, Ludwig; Panje, Cédric (2020). Radiotherapy for lentigo maligna and lentigo maligna melanoma - a systematic review. Radiation oncology, 15(1), p. 174. BioMed Central 10.1186/s13014-020-01615-2

Viktorin-Baier, Pascal; Putora, Paul M.; Schmid, Hans-Peter; Plasswilm, Ludwig; Schwab, Christoph; Thoeni, Armin; Hochreiter, Werner; Prikler, Ladislav; Suter, Stefan; Stucki, Patrick; Müntener, Michael; Blick, Nadja; Schiefer, Hans; Güsewell, Sabine; Zürn, Karin; Engeler, Daniel (2020). Long-term oncological and functional follow-up in low-dose-rate brachytherapy for prostate cancer: results from the prospective nationwide Swiss registry. BJU international, 125(6), pp. 827-835. Wiley 10.1111/bju.15003

Iseli, Thomas; Fischer, Galina Farina; Panje, Cédric; Glatzer, Markus; Hundsberger, Thomas; Rothermundt, Christian; Schmidt, Barbara; Sirén, Charlotta; Plasswilm, Ludwig; Putora, Paul Martin (2020). Insular Decision Criteria in Clinical Practice: Analysis of Decision-Making in Oncology. Oncology - international journal of cancer research and treatment, 98(6), pp. 438-444. Karger 10.1159/000508132

Panje, Cédric; Lupatsch, J; Barbier, M; Pardo, E; Lorez, M; Dedes, K J; Aebersold, D. M.; Plasswilm, Ludwig; Gautschi, O.; Schwenkglenks, M. (2020). A cost-effectiveness analysis of consolidation immunotherapy with durvalumab in stage III NSCLC responding to definitive radiochemotherapy in Switzerland. Annals of oncology, 31(4), pp. 501-506. Oxford University Press 10.1016/j.annonc.2020.01.007


Panje, Cédric M; Höng, Laura; Hayoz, Stefanie; Baracos, Vickie E; Herrmann, Evelyn; Garcia Schüler, Helena; Meier, Urs R; Henke, Guido; Schacher, Sabina; Hawle, Hanne; Gérard, Marie-Aline; Ruhstaller, Thomas; Plasswilm, Ludwig (2019). Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy. Radiation oncology, 14(1), p. 166. BioMed Central 10.1186/s13014-019-1372-3

Plasswilm, Ludwig; Studer, Gabriela; Aebersold, Daniel; Zwahlen, Daniel R (2019). [Modern Treatment Concepts in Radiation Oncology]. Therapeutische Umschau, 76(4), pp. 209-218. Hogrefe 10.1024/0040-5930/a001086

Riesterer, Oliver; Frank Ciernik, I; Stahel, Rolf A; Xyrafas, Alexandros; Aebersold, Daniel; Plasswilm, Ludwig; Mahmut Ozsahin, E; Zwahlen, Daniel R; Nackaerts, Kristiaan; Zimmermann, Frank; Sabrina Stark, L; Weder, Walter; Krayenbuehl, Jérôme (2019). Pattern of failure after adjuvant radiotherapy following extrapleural pneumonectomy of pleural mesothelioma in the SAKK 17/04 trial. Radiotherapy and oncology, 138, pp. 121-125. Elsevier 10.1016/j.radonc.2019.05.024


Panje, Cedric M; Dedes, Konstantin J; Matter-Walstra, Klazien; Schwenkglenks, Matthias; Gautschi, Oliver; Siano, Marco; Aebersold, Daniel; Plasswilm, Ludwig; Lupatsch, Judith E (2018). A cost-effectiveness analysis of consolidative local therapy in oligometastatic non-squamous non-small cell lung cancer (NSCLC). Radiotherapy and oncology, 129(2), pp. 257-263. Elsevier 10.1016/j.radonc.2018.07.017

Ruhstaller, T; Thuss-Patience, P; Hayoz, S; Schacher, S; Knorrenschild, J R; Schnider, A; Plasswilm, Ludwig; Budach, W; Eisterer, W; Hawle, H; Mariette, C; Hess, V; Mingrone, W; Montemurro, M; Girschikofsky, M; Schmidt, S C; Bitzer, M; Bedenne, L; Brauchli, P and Stahl, M (2018). Neoadjuvant chemotherapy followed by chemoradiation and surgery with and without cetuximab in patients with resectable esophageal cancer: a randomized, open-label, phase III trial (SAKK 75/08). Annals of oncology, 29(6), pp. 1386-1393. Oxford University Press 10.1093/annonc/mdy105

Wirsching, H-G; Tabatabai, G; Roelcke, U; Hottinger, A F; Jörger, F; Schmid, A; Plasswilm, Ludwig; Schrimpf, D; Mancao, C; Capper, D; Conen, K; Hundsberger, T; Caparrotti, F; von Moos, R; Riklin, C; Felsberg, J; Roth, P; Jones, D T W; Pfister, S; Rushing, E J; ... (2018). Bevacizumab plus hypofractionated radiotherapy versus radiotherapy alone in elderly patients with glioblastoma: the randomized, open-label, phase II ARTE trial. Annals of oncology, 29(6), pp. 1423-1430. Oxford University Press 10.1093/annonc/mdy120

von Moos, Roger; Koeberle, Dieter; Schacher, Sabina; Hayoz, Stefanie; Winterhalder, Ralph C; Roth, Arnaud; Bodoky, György; Samaras, Panagiotis; Berger, Martin D.; Rauch, Daniel; Saletti, Piercarlo; Plasswilm, Ludwig; Zwahlen, Daniel; Meier, Urs R; Yan, Pu; Izzo, Paola; Klingbiel, Dirk; Bärtschi, Daniela; Zaugg, Kathrin (2018). Neoadjuvant radiotherapy combined with capecitabine and sorafenib in patients with advanced KRAS-mutated rectal cancer: A phase I/II trial (SAKK 41/08). European journal of cancer, 89, pp. 82-89. Elsevier 10.1016/j.ejca.2017.11.005

Panje, Cédric M.; Glatzer, Markus; Sirén, Charlotta; Plasswilm, Ludwig; Putora, Paul M. (2018). Treatment Options in Oncology. JCO Clinical Cancer Informatics, 2(1), pp. 1-10. American Society of Clinical Oncology 10.1200/cci.18.00017


Panje, Cédric M; Glatzer, Markus; von Rappard, Joscha Stefan; Rothermundt, Christian; Hundsberger, Thomas; Zumstein, Valentin; Plasswilm, Ludwig; Putora, Paul Martin (2017). Applied Swarm-based medicine: collecting decision trees for patterns of algorithms analysis. BMC Medical research methodology, 17(1), p. 123. BioMed Central 10.1186/s12874-017-0400-y

Warschkow, Rene; Güller, Ulrich; Cerny, Thomas; Schmied, Bruno Martin; Plasswilm, Ludwig; Putora, Paul Martin (2017). Secondary malignancies after rectal cancer resection with and without radiation therapy: A propensity-adjusted, population-based SEER analysis. Radiotherapy and oncology, 123(1), pp. 139-146. Elsevier 10.1016/j.radonc.2017.02.007


Hundsberger, T.; Hottinger, A. F.; Roelcke, U.; Roth, P.; Migliorini, D.; Dietrich, P. Y.; Conen, K.; Pesce, G.; Herrmann, Evelyn; Pica, Alessia; Gross, M. W.; Brügge, D.; Plasswilm, Ludwig; Weller, M.; Putora, P. M. (2016). Patterns of care in recurrent glioblastoma in Switzerland: a multicentre national approach based on diagnostic nodes. Journal of neuro-oncology, 126(1), pp. 175-183. Springer 10.1007/s11060-015-1957-0

Ghadjar, Pirus; Pöttgen, Christoph; Joos, Daniela; Hayoz, Stefanie; Baumann, Michael; Bodis, Stephan; Budach, Wilfried; Studer, Gabriela; Stromberger, Carmen; Zimmermann, Frank; Kaul, David; Plasswilm, Ludwig; Olze, Heidi; Bernier, Jacques; Wust, Peter; Aebersold, Daniel; Budach, Volker (2016). Haemoglobin and creatinine values as prognostic factors for outcome of concurrent radiochemotherapy in locally advanced head and neck cancers : Secondary results of two European randomized phase III trials (ARO 95-06, SAKK 10/94). Strahlentherapie und Onkologie, 192(8), pp. 552-560. Springer-Medizin-Verlag 10.1007/s00066-016-0999-3

Glatzer, Markus; Putora, Paul Martin; Plasswilm, Ludwig (2016). Radioimmuntherapie – die neue Strategie im Kampf gegen Krebs? Schweizer Zeitschrift für Onkologie, 2, pp. 10-14. Rosenfluh Publikationen AG

Putora, Paul Martin; Engeler, D.; Haile, S. R.; Graf, N.; Buchauer, K.; Schmid, H. P.; Plasswilm, Ludwig (2016). Erectile function following brachytherapy, external beam radiotherapy, or radical prostatectomy in prostate cancer patients. Strahlentherapie und Onkologie, 192(3), pp. 182-189. Springer-Medizin-Verlag 10.1007/s00066-015-0928-x

Eliçin, Olgun; Schmücking, Michael; Brömme, Jens; Rauch, Daniel; Ambarcioglu, Pinar; Plasswilm, Ludwig; Geretschläger, Andreas; Ghadjar, Pirus; Giger, Roland; Aebersold, Daniel (2016). Volumetric regression ratio of the primary tumor and metastatic lymph nodes after induction chemotherapy predicts overall survival in head and neck squamous cell carcinoma: a retrospective analysis. JBUON, 21(1), pp. 175-181. Imprimatur Publications


Ghadjar, Pirus; Hayoz, Stefanie; Bernhard, Jürg; Zwahlen, Daniel R; Hölscher, Tobias; Gut, Philipp; Guckenberger, Matthias; Hildebrandt, Guido; Müller, Arndt-Christian; Plasswilm, Ludwig; Papachristofilou, Alexandros; Stalder, Lukas; Biaggi-Rudolf, Christine; Sumila, Marcin; Kranzbühler, Helmut; Najafi, Yousef; Ost, Piet; Azinwi, Ngwa C; Reuter, Christiane; Bodis, Stephan; ... (2015). Acute Toxicity and Quality of Life After Dose-Intensified Salvage Radiation Therapy for Biochemically Recurrent Prostate Cancer After Prostatectomy: First Results of the Randomized Trial SAKK 09/10. Journal of clinical oncology, 33(35), pp. 4158-4166. American Society of Clinical Oncology 10.1200/JCO.2015.63.3529

Panje, Cédric M; Dal Pra, Alan; Zilli, Thomas; R Zwahlen, Daniel; Papachristofilou, Alexandros; Herrera, Fernanda G; Matzinger, Oscar; Plasswilm, Ludwig; Putora, Paul Martin (2015). Consensus and differences in primary radiotherapy for localized and locally advanced prostate cancer in Switzerland: A survey on patterns of practice. Strahlentherapie und Onkologie, 191(10), pp. 778-786. Springer-Medizin-Verlag 10.1007/s00066-015-0849-8

Panje, Cedric; Panje, Thierry; Putora, Paul Martin; Kim, Suk-Kyum; Haile, Sarah; Aebersold, Daniel; Plasswilm, Ludwig (2015). Guidance of treatment decisions in risk-adapted primary radiotherapy for prostate cancer using multiparametric magnetic resonance imaging: a single center experience. Radiation oncology, 10, p. 47. BioMed Central 10.1186/s13014-015-0338-3

Ghadjar, Pirus; Hayoz, Stefanie; Zimmermann, Frank; Bodis, Stephan; Kaul, David; Badakhshi, Harun; Bernier, Jacques; Studer, Gabriela; Plasswilm, Ludwig; Budach, Volker; Aebersold, Daniel (2015). Impact of weight loss on survival after chemoradiation for locally advanced head and neck cancer: secondary results of a randomized phase III trial (SAKK 10/94). Radiation oncology, 10, p. 21. BioMed Central 10.1186/s13014-014-0319-y


Sassowsky, Manfred; Gut, Philipp; Hölscher, Tobias; Hildebrandt, Guido; Müller, Arndt-Christian; Najafi, Yousef; Kohler, Götz; Kranzbühler, Helmut; Guckenberger, Matthias; Zwahlen, Daniel R; Azinwi, Ngwa C; Plasswilm, Ludwig; Takacs, Istvan; Reuter, Christiane; Sumila, Marcin; Manser, Peter; Ost, Piet; Böhmer, Dirk; Pilop, Christiane; Aebersold, Daniel; ... (2013). Use of EORTC Target Definition Guidelines for Dose-Intensified Salvage Radiation Therapy for Recurrent Prostate Cancer: Results of the Quality Assurance Program of the Randomized Trial SAKK 09/10. International journal of radiation oncology, biology, physics, 87(3), pp. 534-541. Elsevier 10.1016/j.ijrobp.2013.06.2053

Brömme, J. O.; Schmücking, M.; Arnold, A.; Giger, R.; Rauch, D.; Leiser, D.; Plasswilm, L.; Geretschläger, A.; Ghadjar, P.; Aebersold, D. M. (2013). Taxane-containing induction chemotherapy followed by definitive chemoradiotherapy. Outcome in patients with locally advanced head and neck cancer. Strahlentherapie und Onkologie, 189(8), pp. 618-624. Heidelberg: Springer Berlin Heidelberg 10.1007/s00066-013-0397-z

Provide Feedback